Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chiu

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2019
Modeling conduit choice for valve-sparing aortic root replacement on biomechanics with a 3-dimensional-printed heart simulatorMichael J Paulsen, Patpilai Kasinpila, Annabel M Imbrie-Moore, et al.
Circulation. Cardiovascular Imaging|April 1, 2017
Computed Tomography Imaging Features in Acute Uncomplicated Stanford Type-B Aortic Dissection Predict Late Adverse EventsAnna M Sailer, Sander M J van Kuijk, Patricia J Nelemans, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2025
Is there a role of PSMA-PET in focal therapy planning and follow-up?Rossella Nicoletti, Andrea Alberti, Vineet Gauhar, et al.
Journal of Medicinal Chemistry|February 13, 2013
Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseasesJuan-Miguel Jimenez, Dean Boyall, Guy Brenchley, et al.
ACS Medicinal Chemistry Letters|August 17, 2019
Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune EncephalomyelitisPhilip N Collier, Heather C Twin, Ronald M A Knegtel, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology Oncology|May 3, 2025
Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative GroupSunny B Nalavenkata, Emily Vertosick, Alberto Briganti, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Thoracic and Cardiovascular Surgery|February 13, 2019
Modeling conduit choice for valve-sparing aortic root replacement on biomechanics with a 3-dimensional-printed heart simulatorMichael J Paulsen, Patpilai Kasinpila, Annabel M Imbrie-Moore, et al.
Circulation. Cardiovascular Imaging|April 1, 2017
Computed Tomography Imaging Features in Acute Uncomplicated Stanford Type-B Aortic Dissection Predict Late Adverse EventsAnna M Sailer, Sander M J van Kuijk, Patricia J Nelemans, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2025
Is there a role of PSMA-PET in focal therapy planning and follow-up?Rossella Nicoletti, Andrea Alberti, Vineet Gauhar, et al.
Journal of Medicinal Chemistry|February 13, 2013
Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseasesJuan-Miguel Jimenez, Dean Boyall, Guy Brenchley, et al.
ACS Medicinal Chemistry Letters|August 17, 2019
Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune EncephalomyelitisPhilip N Collier, Heather C Twin, Ronald M A Knegtel, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology Oncology|May 3, 2025
Variation in Prostate Magnetic Resonance Imaging Performance: Data from the Prostate Biopsy Collaborative GroupSunny B Nalavenkata, Emily Vertosick, Alberto Briganti, et al.
Cancers|January 11, 2022
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future PerspectivesAlexander Kretschmer, Roderick C N van den Bergh, Alberto Martini, et al.
European Urology Oncology|June 26, 2025
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
Pageof 12